Advancing quantitative NAMs for skin sensitization risk assessment – Collaborative work within IDEA QRA-NAMs Working Group A new article published in Regulatory Toxicology and Pharmacology presents the outcomes of collaborative work within the […]
Click image to view the Newsletter in browser. Text version: SenzaGen Newsletter Q4, 2025 As 2025 draws to a close: This quarter caps a year of significant progress in advancing […]
Click image to view the Newsletter in browser. Safe dose levels for sensitizers, NESIL values for HRIPT, and PoD-based QRA Skin sensitization potency assessment has been in the spotlight at […]
Supporting industry decision-making and hypoallergenicity claims using an experimental setup combining GARD®skin Medical Device and Dose-Response protocols. Presented at 2025 Eurotox Download a copy in PDF Conclusion This case […]
In vitro skin sensitization potency assessment using GARD®skin Dose-Response: A case study on natural extracts-based skin-binding dyes and dye precursors Presented at 2025 Eurotox Download a copy in PDF […]
Comparative analysis of skin sensitization thresholds for Essential Oils: Human, murine, and GARD®skin Dose-Response Presented at 2025 Eurotox Download a copy in PDF Conclusion NESIL predictions from GARD® were […]
Click image to view the Newsletter in browser. SenzaGen Newsletter 2025 Q2 GARD®skin is now included in OECD TG 497 We are excited to announce that the GARDskin assay (OECD TG […]
